537 related articles for article (PubMed ID: 26399371)
41. Contemporary management of prolactinomas.
Liu JK; Couldwell WT
Neurosurg Focus; 2004 Apr; 16(4):E2. PubMed ID: 15191331
[TBL] [Abstract][Full Text] [Related]
42. Operative treatment of cystic prolactinomas: a retrospective study.
Su W; He K; Yang Y; Xu J; Li X; Tang H; Yang J; Yang L
BMC Endocr Disord; 2023 May; 23(1):99. PubMed ID: 37143054
[TBL] [Abstract][Full Text] [Related]
43. Clinical management of prolactinomas.
Webster J
Baillieres Best Pract Res Clin Endocrinol Metab; 1999 Oct; 13(3):395-408. PubMed ID: 10909431
[TBL] [Abstract][Full Text] [Related]
44. Prolactinomas in children and adolescents.
Colao A; Loche S
Endocr Dev; 2010; 17():146-159. PubMed ID: 19955764
[TBL] [Abstract][Full Text] [Related]
45. Current management of prolactinomas.
Nomikos P; Buchfelder M; Fahlbusch R
J Neurooncol; 2001 Sep; 54(2):139-50. PubMed ID: 11761431
[TBL] [Abstract][Full Text] [Related]
46. Clinical management of difficult to treat macroprolactinomas.
Sahakian N; Castinetti F; Dufour H; Graillon T; Romanet P; Barlier A; Brue T; Cuny T
Expert Rev Endocrinol Metab; 2019 May; 14(3):179-192. PubMed ID: 30913932
[TBL] [Abstract][Full Text] [Related]
47. [Treatment of pituitary adenomas].
Mezosi E; Nemes O
Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
[TBL] [Abstract][Full Text] [Related]
48. Surgical treatment of prolactinomas: cons.
Bloomgarden E; Molitch ME
Endocrine; 2014 Dec; 47(3):730-3. PubMed ID: 25112227
[TBL] [Abstract][Full Text] [Related]
49. [Current diagnosis and treatment of hyperprolactinemia].
Melgar V; Espinosa E; Sosa E; Rangel MJ; Cuenca D; Ramírez C; Mercado M
Rev Med Inst Mex Seguro Soc; 2016; 54(1):111-21. PubMed ID: 26820213
[TBL] [Abstract][Full Text] [Related]
50. Resistant prolactinomas: a case series of 26 patients.
Eshkoli T; Fraenkel M; Zaid D; Cohen D; Yoel U; Tsvetov G; Gorshtein A; Goldbart A; Greenman Y; Shimon I
Endocrine; 2022 Aug; 77(2):349-356. PubMed ID: 35604631
[TBL] [Abstract][Full Text] [Related]
51. Outcomes of transsphenoidal surgery in dopamine agonist-resistant prolactinomas: a retrospective study.
Wei L; Wei X
Hormones (Athens); 2021 Dec; 20(4):745-752. PubMed ID: 34275094
[TBL] [Abstract][Full Text] [Related]
52. Medical versus surgical management of prolactinomas.
Oh MC; Kunwar S; Blevins L; Aghi MK
Neurosurg Clin N Am; 2012 Oct; 23(4):669-78. PubMed ID: 23040751
[TBL] [Abstract][Full Text] [Related]
53. Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas.
Sala E; Bellaviti Buttoni P; Malchiodi E; Verrua E; Carosi G; Profka E; Rodari G; Filopanti M; Ferrante E; Spada A; Mantovani G
J Endocrinol Invest; 2016 Dec; 39(12):1377-1382. PubMed ID: 27245604
[TBL] [Abstract][Full Text] [Related]
54. Italian Guidelines for the Management of Prolactinomas.
Cozzi R; Simona Auriemma R; De Menis E; Esposito F; Ferrante E; Iatì G; Mazzatenta D; Poggi M; Rudà R; Tortora F; Cruciani F; Mitrova Z; Saulle R; Vecchi S; Basile M; Cappabianca P; Paoletta A; Papini E; Persichetti A; Samperi I; Scoppola A; Bozzao A; Caputo M; Doglietto F; Ferraù F; Lania AG; Laureti S; Lello S; Locatelli D; Maffei P; Minniti G; Peri A; Ruini C; Settanni F; Silvani A; Veronese N; Grimaldi F; Attanasio R
Endocr Metab Immune Disord Drug Targets; 2023; 23(12):1459-1479. PubMed ID: 37171003
[TBL] [Abstract][Full Text] [Related]
55. Management of Dopamine Agonist-Resistant Prolactinoma.
Maiter D
Neuroendocrinology; 2019; 109(1):42-50. PubMed ID: 30481756
[TBL] [Abstract][Full Text] [Related]
56. Prolactinoma and pregnancy: From the wish of conception to lactation.
Maiter D
Ann Endocrinol (Paris); 2016 Jun; 77(2):128-34. PubMed ID: 27130071
[TBL] [Abstract][Full Text] [Related]
57. The Role of Surgery in the Management of Prolactinomas.
Donoho DA; Laws ER
Neurosurg Clin N Am; 2019 Oct; 30(4):509-514. PubMed ID: 31471058
[TBL] [Abstract][Full Text] [Related]
58. Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients.
Vroonen L; Jaffrain-Rea ML; Petrossians P; Tamagno G; Chanson P; Vilar L; Borson-Chazot F; Naves LA; Brue T; Gatta B; Delemer B; Ciccarelli E; Beck-Peccoz P; Caron P; Daly AF; Beckers A
Eur J Endocrinol; 2012 Nov; 167(5):651-62. PubMed ID: 22918301
[TBL] [Abstract][Full Text] [Related]
59. First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center.
Andereggen L; Frey J; Andres RH; Luedi MM; El-Koussy M; Widmer HR; Beck J; Mariani L; Seiler RW; Christ E
J Endocrinol Invest; 2021 Dec; 44(12):2621-2633. PubMed ID: 33847973
[TBL] [Abstract][Full Text] [Related]
60. Management of prolactinomas.
Molitch ME
Annu Rev Med; 1989; 40():225-32. PubMed ID: 2658749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
